Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
76.6M
-
Number of holders
-
168
-
Total 13F shares, excl. options
-
84.6M
-
Shares change
-
+3.65M
-
Total reported value, excl. options
-
$1.01B
-
Value change
-
+$28.7M
-
Put/Call ratio
-
0.14
-
Number of buys
-
91
-
Number of sells
-
-82
-
Price
-
$11.88
Significant Holders of Nurix Therapeutics, Inc. - Common Stock (NRIX) as of Q1 2025
204 filings reported holding NRIX - Nurix Therapeutics, Inc. - Common Stock as of Q1 2025.
Nurix Therapeutics, Inc. - Common Stock (NRIX) has 168 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 84.6M shares
.
Largest 10 shareholders include FMR LLC (10.3M shares), BlackRock, Inc. (7.99M shares), Deep Track Capital, LP (5.5M shares), VANGUARD GROUP INC (4.42M shares), Redmile Group, LLC (4.05M shares), COMMODORE CAPITAL LP (3.98M shares), BAKER BROS. ADVISORS LP (3.88M shares), WELLINGTON MANAGEMENT GROUP LLP (3.19M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.91M shares), and STATE STREET CORP (2.86M shares).
This table shows the top 168 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.